Medicinal aerosol solution formulation with biocompatible polymer
US6416742B1 · kind B1 · utility
16Cited by
43References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2000 |
| Grant date | Jul 9, 2002 |
| Priority date | — |
| Expiry date | Aug 9, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/593
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods, compounds, and medicinal formulations utilizing biocompatible polymers for delivery of a drug, particularly for solubilizing, stabilizing and/or providing sustained release of drug from topical, implantable, and inhalation systems. Many of the methods, compounds, and medicinal formulations are particularly suitable for oral and/or nasal inhalation and use polymers of the formula —[X—R1—C(O)]— wherein each R1 is an independently selected organic group that links the —X— group to the carbonyl group, and each X is independently oxygen, sulfur, or catenary nitrogen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.